ClinicalTrials.gov
public full text
Public Domain
The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension
This study aims to investigate safety and efficacy of Occlutech® AFR device in patients with severe pulmonary hypertension (PH).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder#1031522
- Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension#391971
- Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension#268117
- Empagliflozin in Pulmonary Arterial Hypertension#474847
- RAFT - Pace &Ablate#1213638
Record · ID 1211487
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive